Spotlight on – The Future of Oncology Clinical Trials
We present the latest insight and analysis of the rapidly evolving field of cancer therapeutics and immuno-therapy, with a particular focus on what current innovation exists and means for the future of this critical area of medicine.
With a pipeline of as many as 600 oncology related treatments in the works, the next decade will see the pharmaceutical industry and its research partners face challenges in turning a range of promising scientific ideas into safe, effective medicines to extend the lives of cancer patients.
As tumour definitions become more granular, and treatments more specific and personalised, a new array of challenges are coming into view, central to which is evolving the clinical trial process, while remaining cost-effective.
Spotlight on the Future of Oncology Clinical Trials is a combination of resources jointly developed by pharmaphorum and QuintilesIMS to explore how these challenges can be met, by drawing on insights from QuintilesIMS’ experts. This includes in-depth discussion of the latest innovations, best new approaches to trial management, processes and technology to help focus decision-making and speed development times.
#pharmaviewsandanalysis
#pharmanews
Innovations in cancer drug research
September 4, 2017
A new age: the real-world development pathway
December 13, 2016Pharma must be prepared to work collaboratively to establish the best benefit-risk profiles and outcomes.
ESMO review: advances in immunotherapy, EMA dialogue and patient power
October 20, 2016QuintilesIMS’s Cristina Oliva talks to pharmaphorum about her personal highlights from this year’s congress.
Infographic: Solving the challenges of immuno-oncology trials
October 12, 2016
Immuno-oncology: how to keep ahead in a fast-moving field
October 7, 2016In the last two years, the first PD-1 checkpoint inhibitor drugs to reach patients have launched a revolution in cancer care.
On Demand: The Top 5 Challenges in Immuno-Oncology Trials
September 28, 2016
Oncology – the current landscape and what it means for the future
September 4, 2017
Top 5 challenges of immuno-oncology clinical trials
June 7, 2017Learn innovative solutions to address these challenges
Managing Multi-Arm Studies in an Evolving Immuno-Oncology Landscape
June 7, 2017Collaborate with CROs and sites to help minimize risks
Need Help Navigating a Rapidly Changing Oncology Landscape?
February 1, 2017Cancer: Localized data leading to real-world care
October 13, 2016Advancing Cancer Treatments in the Age of Precision Medicine
October 13, 2016Closing the loop in genotype-matched oncology trial recruitment
October 13, 2016
Giving drug candidates the greatest chance for success
October 13, 2016